Skip to main content
B

Bal Pharma Ltd. — Investor Relations & Filings

Ticker · BALPHARMA ISIN · INE083D01012 LEI · 254900F3KMK38GUDIW74 BSE.NS Manufacturing
Filings indexed 558 across all filing types
Latest filing 2026-05-12 Board/Management Inform…
Country IN India
Listing BSE.NS BALPHARMA

About Bal Pharma Ltd.

https://www.balpharma.com/

Bal Pharma Ltd. specializes in the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Formulations. The organization operates manufacturing facilities compliant with international quality standards, including WHO-GMP certifications. Its product portfolio encompasses a wide range of therapeutic segments, including diabetology, cardiology, gastroenterology, oncology, and pain management. Notable APIs in its catalog include Gliclazide, Ebastine, and Benzydamine. The company maintains an integrated business model, supporting operations from research and development to large-scale production. Bal Pharma serves a global clientele, exporting its products to numerous international markets across multiple continents, while focusing on the delivery of high-quality medicinal products and specialized formulations.

Recent filings

Filing Released Lang Actions
Intimation on resignation of Company Secretary & Compliance officer.
Board/Management Information Classification · 89% confidence The document is a stock exchange filing under SEBI Listing Regulations announcing the resignation of the Company Secretary & Compliance Officer (a key managerial position). It provides details of the cessation of service, effective date, and related annexure. There is no financial data, no call transcript, no report attachments – it is clearly an announcement of a management change. Therefore, it falls under Board/Management Information.
2026-05-12 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-17 English
Structural Digital Database
Regulatory Filings
2026-04-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-06 English
Trading Window
Regulatory Filings
2026-03-23 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.